Trial Profile
A prospective, observational study to evaluate the predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 16 Dec 2015 New trial record